AAN 2021
AMERICAN ACADEMY OF NEUROLOGY ANNUAL MEETING 2021
April 17-22, 2021 |
Virtual
Von Willebrand factor as a potentially useful biomarker for traumatic brain injury
Evobrutinib reduces neuroaxonal damage in multiple sclerosis
An early portrait of neuropathological features of COVID-19
Vagus nerve stimulations paired with upper extremity rehabilitation as a potential treatment for post-ischemic stroke patients
Siponimod for the treatment of patients with secondary progressive multiple sclerosis: Results from the expand open-label extension interim analysis of up to 5 years
Safety of oral rimegepant in adults with migraine and cardiovascular risk factors
9-month results from the phase 3 HELIOS-Aa study of vutrisiran in patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy
Efficacy and safety of intranasal zavegepant for the acute treatment of migraine